CLINICAL_TRIALS
research
· 2012-05-16
Clinical Trial Update: DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas [Phase 2]
Summary
A clinical trial update indicating completion of a Phase 2 study of the investigational drug DX-8951f in metastatic pancreatic cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED